Glenmark Pharmaceuticals reports 86% drop in Q1 consolidated net profit
The total consolidated income of the company increased by 0.46% at Rs 3290.88 crore for Q1FY26
Glenmark Pharmaceuticals has reported result for first quarter ended June 30, 2025 (Q1FY26).
The company has reported 27.22% fall in its net profit at Rs 330.23 crore for the quarter ended June 30, 2025 as compared to Rs 453.73 crore for the same quarter in the previous year. However, the total income of the company increased by 3.32% at Rs 2464.26 crore for Q1FY26 as compared to Rs 2385.19 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 86.23% drop in its net profit at Rs 46.87 crore for Q1FY26 as compared to Rs 340.27 crore for the same quarter in the previous year. However, the total income of the company increased by 0.46% at Rs 3290.88 crore for Q1FY26 as compared to Rs 3275.68 crore for the corresponding quarter previous year.
